Moujalled DM, Brown FC, Chua CC, et al. Acquired mutations in BAX confer resistance to BH3-mimetic therapy in acute myeloid leukemia. Blood. 2023;141(6):634-644.

Detalles Bibliográficos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The American Society of Hematology 2023
Materias:
Erratum
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10517205/
https://www.ncbi.nlm.nih.gov/pubmed/37535365
http://dx.doi.org/10.1182/blood.2023020968

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10517205/
https://www.ncbi.nlm.nih.gov/pubmed/37535365
http://dx.doi.org/10.1182/blood.2023020968

Ejemplares similares